Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

Clinical trial NCT07167251 · RECRUITING

Trial details

NCT number: NCT07167251
Sponsor: University Hospital, Basel, Switzerland
Status: RECRUITING
Study type: OBSERVATIONAL

Immune Related Adverse Events Immune-Mediated Hepatitis Cancer

Start date: 2025-08-25
Primary completion: 2026-12-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.